Long M

ORCID: 0000-0002-4517-1829 · 7 papers in corpus
review 2026
Frontiers in cell and developmental biology ·doi:10.3389/fcell.2026.1803566

BACKGROUND: Germline mutations in genes governing DNA repair, cell cycle regulation, and epigenetic modification are now recognized as common etiological factors for both cancer predisposition and reproductive dysfunction. This reveals a pr…

review 2023
Environmental research ·doi:10.1016/j.envres.2022.114650

While human regulatory risk assessment (RA) still largely relies on animal studies, new approach methodologies (NAMs) based on in vitro, in silico or non-mammalian alternative models are increasingly used to evaluate chemical hazards. Moreo…

lab-animal 2020
Cell cycle (Georgetown, Tex.) ·doi:10.1080/15384101.2020.1831254

Pancreatic cancer (PC) is a leading cause of cancer mortality and is expected to continue increasing incidence. Abnormally expressed microRNAs have been demonstrated tightly correlated with the development and progression of PC. However, th…

lab-animal 2020
APL bioengineering ·doi:10.1063/5.0001994

Cyclic myometrial contractions of the non-pregnant uterus induce intra-uterine peristaltic flows, which have important roles in transport of sperm and embryos during early stages of reproduction. Hyperperistalsis in young females may lead t…

case-report 2017
AME case reports ·doi:10.21037/acr.2017.09.03

A 48-year-old woman was admitted for pectoralgia and dyspnea. Tomography revealed a giant lung bulla with a mass arose from the bulla wall in the left lower lobes, and left lower lobes pulmonary wedge resection was performed through video-a…

lab-animal 2015
International journal of molecular medicine ·doi:10.3892/ijmm.2015.2082

Endometriosis is a prevalent and complex gynecological disease which affects 10% of women of reproductive age. Certain studies have suggested that a substantial number of microRNAs (miRNAs or miRs) are aberrantly or differentially expressed…

observational 2012
BMC cancer ·doi:10.1186/1471-2407-12-161

BACKGROUND: In premenopausal women, endocrine adjuvant therapy for breast cancer primarily consists of tamoxifen alone or with ovarian suppressive strategies. Toremifene is a chlorinated derivative of tamoxifen, but with a superior risk-ben…